---
title: "Taltz (ixekizumab), all indications: Specific populations questions"
description: "Specific populations questions on Taltz (ixekizumab) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Pregnancy and breastfeeding. Questions: Is Taltz safe during pregnancy? Can you breastfeed while taking Taltz? What should be done after a Taltz overdose? 3 questions quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/taltz/specific-populations"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T16:49:54-05:00"
---

# Taltz (ixekizumab), all indications: Specific populations questions

Manufacturer: Eli Lilly and Company  
Prescribing information: [Taltz](https://uspl.lilly.com/taltz/taltz.html#pi)  
Indication pages: [Plaque psoriasis](https://www.evicenter.com/medical-information/taltz--plaque-psoriasis)

## Pregnancy and breastfeeding

<a id="taltz-pregnancy"></a>

### Is Taltz safe during pregnancy?

> “There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to TALTZ during pregnancy. Pregnant women exposed to TALTZ are encouraged to enroll in the TALTZ Pregnancy Registry by calling 1-800-284-1695. Contact information for the registry is also available on http://www.pregnancyregistry.lilly.com.”

Source: [TALTZ: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/taltz/taltz.html#pi:~:text=There%20is%20a%20pregnancy%20exposure,is%20also%20available%20on%20http%3A%2F%2Fwww.pregnancyregistry.lilly.com.)

> “Available data from the published literature and the pharmacovigilance database with TALTZ use in pregnant women are insufficient to evaluate for a drug-associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes.”

Source: [TALTZ: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/taltz/taltz.html#pi:~:text=Available%20data%20from%20the%20published,adverse%20maternal%20or%20fetal%20outcomes.)

> “Human IgG is known to cross the placental barrier; therefore, TALTZ may be transmitted from the mother to the developing fetus. An embryofetal development study conducted in pregnant monkeys during organogenesis at doses up to 19 times the maximum recommended human dose (MRHD) revealed no evidence of harm to the developing fetus. When dosing was continued until parturition, neonatal deaths were observed at 1.9 times the MRHD [see Data]. The clinical significance of these nonclinical findings is unknown.”

Source: [TALTZ: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/taltz/taltz.html#pi:~:text=Human%20IgG%20is%20known%20to,these%20nonclinical%20findings%20is%20unknown.)

<a id="taltz-breastfeeding"></a>

### Can you breastfeed while taking Taltz?

> “There are no available data on the presence of ixekizumab in human milk, the effects on the breastfed infant, or the effects on milk production. Ixekizumab was detected in the milk of lactating cynomolgus monkeys. When a drug is present in animal milk, it is likely that the drug will be present in human milk. The developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for TALTZ and any potential adverse effects on the breastfed infant from TALTZ or from the underlying maternal condition.”

Source: [TALTZ: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/taltz/taltz.html#pi:~:text=There%20are%20no%20available%20data,from%20the%20underlying%20maternal%20condition.)

## Specific populations

<a id="taltz-overdose"></a>

### What should be done after a Taltz overdose?

> “If you inject more TALTZ than prescribed, call your or your child's healthcare provider or go to the nearest emergency room right away.”

Source: [TALTZ: Prescribing information, captured 2026-11-14](https://uspl.lilly.com/taltz/taltz.html#pi:~:text=If%20you%20inject%20more%20TALTZ,nearest%20emergency%20room%20right%20away.)

Note: This passage is from the Medication Guide printed with the Prescribing Information. The contents of the Prescribing Information list no Overdosage section.

## Related pages
- [Medical information: Taltz (ixekizumab): All indications](https://www.evicenter.com/medical-information/taltz)
- [Indication](https://www.evicenter.com/medical-information/taltz/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/taltz/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/taltz/safety)
- [Dosing and administration](https://www.evicenter.com/medical-information/taltz/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/taltz/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/taltz/access-and-coverage)
